Online ISSN: 2515-8260

Cross-sectional study to determine the prevalence of telogen effluvium among patients experiencing COVID-19 infection or vaccination in Saudi Arabia and Arabic countries

Main Article Content

Waleed Alsalhi, MD 1* , Yazeed Almulhim, MBBS2 , Naiem T. Issa, MD, PhD3

Abstract

Background: Telogen effluvium (TE) after COVID-19 infection or vaccination is a common sequelae in dermatology clinics. Objective: to study the prevalence of telogen effluvium in COVID-19 patients and its association with COVID vaccine. Methods: Cross-sectional study via online questionnaire in Saudi Arabia and other Arabic countries.

Article Details